RAPS Convergence

2026-CONV-WhyAttend-Image1-510x780.png

RAPS Convergence

Where the regulatory community gathers to discuss the topics you want to learn, with expert speakers offering practical insights you can apply right away.

RAPS Convergence is the largest and most well-recognized annual gathering of regulatory affairs professionals and innovators worldwide. RAPS Convergence unites representatives from industry, global regulatory bodies, and research, academic, and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.

RAPS Convergence is designed to educate and empower professionals about the ever-evolving healthcare product regulatory environment within an interactive forum that facilitates community exchange, connections, and knowledge sharing.

RAPS Convergence 2026 by the Numbers*

Charlotte, North Carolina

1700

Attendees

30

Countries

5

Continents

270 +

Industry Experts

6

Health Authorities

5

Notified Bodies

Thank You, RAPS Community!

Regulatory and quality professionals assembled in the Queen City for three days of education, connection, and celebration of 50 years of regulatory affairs at RAPS Convergence 2026.

Learn more about RAPS Convergence

Please join our email list.

Learn more

Next Stop: Minneapolis

RAPS is excited and looking forward to gathering with the regulatory community in Minneapolis, MN, in 2027!

19-21 September 2027
18-19 September (Preconference Workshops)
Minneapolis Convention Center
Minneapolis, Minnesota, USA

Interested in Speaking?

You can help us shape next year’s agenda with hot topics in regulatory affairs. Join our email list to receive notifications about the 2027. Call for Proposals (expected to open in late 2026).

2027-CONV-Logo-510x795.png

Past Events

Pittsburgh Pennsylvania

RAPS Convergence 2025 - Recap
Pittsburgh, Pennsylvania, USA

2025 Agenda

Long Beach California

RAPS Convergence 2024 - Recap
Long Beach, California, USA

2024 Agenda

Convergence Planning Committee

Committee Chair

Chris Whalley
Chris Whalley

Sr. Director & Head of Global
Regulatory Intelligence
& Analysis, Pfizer

Committee Vice Chair

Amra Racic
Amra Racic

VP of Global Government Strategy,
Veeva MedTech

Members - Medical Devices

Francis Dekker
Francis Dekker, PhD

Director, Global Regulatory Affairs, Thermo Fisher Scientific

Tracey Fox
Tracey Fox, RAC

Vice President, Regulatory Affairs, Surgical & Interventional Solutions Division, Olympus Corporation

Niedre Heckman
Niedre Heckman, PhD, MPH, FRAPS

Founder, Regulatory Affairs Consultant and Writer, NOMSA Regulatory and Writing

Sabina Hoekstra-van den Bosch
Sabina Hoekstra-van den Bosch, FRAPS

Global Director Regulatory Strategy, TÜV SÜD Product Service GmbH

Angelina Lisandrelli
Angelina Lisandrelli

Director of Global Regulatory, Advertising & Promotion, Intuitive Surgical

Monika McDole-Russell
Monika McDole-Russell, MS, RAC

Sr. Director, Reg Intelligence and Ad/Pro, Intutive Surgical

Susan Speicher
Susan Speicher, MSc, RAC

Independent Consultant, Speicher Regulatory Services

Members - Pharmaceuticals

Sai Bhamidipati
Sai Bhamidipati, MS, RAC, LSS-GB

Director, Regulatory Affairs CMC, Moderna

Chris Celeste
Chris (Charles) Celeste, RAC

Sr Director, Regulatory Policy and Intelligence, LEO Pharma

Jewell Martin
Jewell Martin, MA, MBA, PMP, RAC

Director US Regulatory Policy, BioMarin Pharmaceutical

Michelle Meng
Michelle Meng, PhD,
RAC

Co-founder and Principal, Pacific Horizon Biopharma Consulting

Kamana Singh
Kamana Singh, MVSc, PSM-MMB, MBA, RAC

CEO & Founder, APS Pharma Solutions

Tyler Vandivort
Tyler Vandivort, PhD, DABT, RAC

Regulatory Affairs Lead, UCB Biopharma

Karen Zimm
Karen Zimm, PhD, RAC

Professor, Adjunct, Temple University, School of Pharmacy

 

Strategic Advisors

Diana Salditt
Diana Salditt, FRAPS

Principal Consultant, Salditt Regulatory Consulting

Sonday Kelly
Sonday Kelly, MS, RAC, PMP

Associate Director of Regulatory Programs
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Department of Health and Human Services

Sabine Haubenreisser
Sabine Haubenreisser, MSc, PhD, FRAPS

Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency

Thank You to Our 2026 Sponsors 

Premier

Visionary

Sponsor